A targeted proteomics approach for profiling Murine Cytochrome P450 expressions

Journal of Pharmacology and Experimental Therapeutics

Volumn 349, Issue 2, 2014, Pages 221-228

  Hersman, Elisabeth M ^a   Bumpus, Namandjé N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME; CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 2A; CYTOCHROME P450 2B; CYTOCHROME P450 2B9; CYTOCHROME P450 2C; CYTOCHROME P450 2D; CYTOCHROME P450 2D26; CYTOCHROME P450 2E; CYTOCHROME P450 2E1; CYTOCHROME P450 2F; CYTOCHROME P450 2J; CYTOCHROME P450 3A; CYTOCHROME P450 4A; CYTOCHROME P450 4B; CYTOCHROME P450 4B1; CYTOCHROME P450 4F; CYTOCHROME P450 4V; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; FEMALE; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; QUANTITATIVE ANALYSIS; SELECTED REACTION MONITORING ASSAY; SEX DIFFERENCE; TISSUE DISTRIBUTION;

AGE FACTORS; ANIMALS; ANTI-HIV AGENTS; BENZOXAZINES; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; FETUS; MALE; MICE, INBRED BALB C; ORGAN SPECIFICITY; PREGNANCY; PROTEOMICS; SEX FACTORS; TRANSCRIPTOME;

EID: 84898789133     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.212456     Document Type: Article

References (19)

1. Amunom I, Dieter LJ, Tamasi V, Cai J, Conklin DJ, Srivastava S, Martin MV, Guengerich FP, and Prough RA (2011) Cytochromes P450 catalyze the reduction of a,b-unsaturated aldehydes. Chem Res Toxicol 24:1223-1230
2. Avery LB, VanAusdall JL, Hendrix CW, and Bumpus NN (2013) Compartmentalization and antiviral effect of efavirenz metabolites in blood plasma, seminal plasma, and cerebrospinal fluid. Drug Metab Dispos 41:422-429
3. Biéche I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, Beaune P, and de Waziers I (2007) Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 17:731-742
4. Choudhary D, Jansson I, Schenkman JB, Sarfarazi M, and Stoilov I (2003) Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch Biochem Biophys 414:91-100
5. Cressey TR, Stek A, Capparelli E, Bowonwatanuwong C, Prommas S, Sirivatanapa P, Yuthavisuthi P, Neungton C, Huo Y, and Smith E, et al.; IMPAACT P1026s Team (2012) Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum. J Acquir Immune Defic Syndr 59:245-252
6. Ding X and Kaminsky LS (2003) Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43: 149-173
7. Guengerich FP (2008) Cytochrome P450 and chemical toxicology. Chem Res Toxicol 21:70-83
8. Guengerich FP and Cheng Q (2011) Orphans in the human cytochrome P450 superfamily: approaches to discovering functions and relevance in pharmacology. Pharmacol Rev 63:684-699
9. Lange V, Picotti P, Domon B, and Aebersold R (2008) Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 4:222
10. MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, Kern R, Tabb DL, Liebler DC, and MacCoss MJ (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26:966-968
11. Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, and Nebert DW (2004) Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternativesplice variants. Pharmacogenetics 14:1-18
12. Ogburn ET, Jones DR, Masters AR, Xu C, Guo Y and Desta Z (2010) Efavirenz primary and secondary metabolism in vitro and in vivo: identification of novel metabolic pathways and cytochrome P450 2A6 as the principal catalyst of efavirenz 7-hydroxylation. Drug Metab Dispos 38:1218-1229
13. Picotti P, Bodenmiller B, Mueller LN, Domon B, and Aebersold R (2009) Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 138: 795-806
14. Raucy JL and Lasker JM (1991) Isolation of P450 enzymes from human liver. Methods Enzymol 206:577-587
15. Renaud HJ, Cui JY, Khan M, and Klaassen CD (2011) Tissue distribution and gender-divergent expression of 78 cytochrome P450 mRNAs in mice. Toxicol Sci 124:261-277
16. Ward BA, Gorski JC, Jones DR, Hall SD, Flockhart DA, and Desta Z (2003) The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity. J Pharmacol Exp Ther 306: 287-300
17. Wisniewski JR, Zougman A, Nagaraj N, and Mann M (2009) Universal sample preparation method for proteome analysis. Nat Methods 6:359-362
18. Xu M, Ju W, Hao H, Wang G, and Li P (2013) Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance. Drug Metab Rev 45:311-352
19. Zhang QY, Dunbar D, and Kaminsky LS (2003) Characterization of mouse small intestinal cytochrome P450 expression. Drug Metab Dispos 31:1346-1351.